Stephanie C Melkonian1, Dornell Pete2, Melissa A Jim1, Donald Haverkamp1, Charles L Wiggins3, Michael G Bruce4, Mary C White5. 1. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Albuquerque, New Mexico, USA. 2. Department of Epidemiology, University of Washington, Seattle, Washington, USA. 3. New Mexico Tumor Registry, Department of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA. 4. Arctic Investigations Program, Division of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, Anchorage, Alaska, USA. 5. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Abstract
INTRODUCTION: American Indian and Alaska Native (AI/AN) populations have higher gastric cancer rates than the general US population. This study provides a comprehensive overview of incidence rates among AI/AN persons during 2005-2016 compared with non-Hispanic whites (whites). METHODS: Population-based cancer registry data for 2005-2016 were linked with the Indian Health Service patient registration databases to address racial misclassification. Age-adjusted gastric cancer incidence rates were expressed per 100,000 per year. Incidence and trend analyses were restricted to purchased/referred care delivery area counties in 6 geographic regions, comparing gastric cancer incidence rates for AI/AN vs white populations in the United States. RESULTS: Gastric cancer rates were higher in the AI/AN compared with white populations in nearly every US region. Incidence rates for central/distal portions of the stomach were higher in AI/AN individuals compared with whites. Rates of later stage gastric cancer were higher in AI/AN populations overall and in every region except the Pacific Coast and East. Incidence rates decreased significantly over time in both populations. Declining rates in the AI/AN populations were driven by changes in the Pacific Coast and Northern Plains regions. DISCUSSION: AI/AN populations have a disproportionately high incidence of gastric cancer, especially in Alaska. High incidence in the central/distal portions of the stomach among AI/AN populations likely reflects a high prevalence of Helicobacter pylori infection in these populations. These data can be used to develop interventions to reduce risk factors and improve access to health services among AI/AN people at high risk for gastric cancer.
INTRODUCTION: American Indian and Alaska Native (AI/AN) populations have higher gastric cancer rates than the general US population. This study provides a comprehensive overview of incidence rates among AI/AN persons during 2005-2016 compared with non-Hispanic whites (whites). METHODS: Population-based cancer registry data for 2005-2016 were linked with the Indian Health Service patient registration databases to address racial misclassification. Age-adjusted gastric cancer incidence rates were expressed per 100,000 per year. Incidence and trend analyses were restricted to purchased/referred care delivery area counties in 6 geographic regions, comparing gastric cancer incidence rates for AI/AN vs white populations in the United States. RESULTS: Gastric cancer rates were higher in the AI/AN compared with white populations in nearly every US region. Incidence rates for central/distal portions of the stomach were higher in AI/AN individuals compared with whites. Rates of later stage gastric cancer were higher in AI/AN populations overall and in every region except the Pacific Coast and East. Incidence rates decreased significantly over time in both populations. Declining rates in the AI/AN populations were driven by changes in the Pacific Coast and Northern Plains regions. DISCUSSION: AI/AN populations have a disproportionately high incidence of gastric cancer, especially in Alaska. High incidence in the central/distal portions of the stomach among AI/AN populations likely reflects a high prevalence of Helicobacter pylori infection in these populations. These data can be used to develop interventions to reduce risk factors and improve access to health services among AI/AN people at high risk for gastric cancer.
Authors: A J Parkinson; B D Gold; L Bulkow; R B Wainwright; B Swaminathan; B Khanna; K M Petersen; M A Fitzgerald Journal: Clin Diagn Lab Immunol Date: 2000-11
Authors: Cindy Ke Zhou; Ruth M Pfeiffer; Sean D Cleary; Heather J Hoffman; Paul H Levine; Lisa W Chu; Ann W Hsing; Michael B Cook Journal: J Clin Oncol Date: 2014-09-15 Impact factor: 44.544
Authors: B J McMahon; M G Bruce; A Koch; K J Goodman; V Tsukanov; G Mulvad; M L Borresen; F Sacco; D Barrett; S Westby; A J Parkinson Journal: Epidemiol Infect Date: 2015-06-22 Impact factor: 2.451
Authors: Felina M Cordova-Marks; William O Carson; Angela Monetathchi; Alyssa Little; Jennifer Erdrich Journal: Int J Environ Res Public Health Date: 2022-04-29 Impact factor: 4.614
Authors: Sarah H Nash; Garrett L Zimpelman; Keri N Miller; James H Clark; Carla L Britton Journal: Int J Circumpolar Health Date: 2022-12 Impact factor: 1.941
Authors: Fernando P Monroy; Heidi E Brown; Priscilla R Sanderson; Gregory Jarrin; Mimi Mbegbu; Shari Kyman; Robin B Harris Journal: Diseases Date: 2022-03-23
Authors: Leisha D Nolen; Sara Bressler; Stephen M Vindigni; Keri Miller; Sarah Nash Journal: Clin Transl Gastroenterol Date: 2021-06-23 Impact factor: 4.396